The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics

The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics

Abstract Background The PARADIGHM registry of adult and pediatric patients with chronic hypoparathyroidism evaluates the long-term safety and effectiveness of treatment with recombinant human parathyroid hormone, rhPTH(1-84), and describes the clinical disease course under conditions of routine clin...

Full description

Bibliographic Details
Main Authors: Neil Gittoes, Lars Rejnmark, Steven W. Ing, Maria Luisa Brandi, Sigridur Björnsdottir, Stefanie Hahner, Lorenz C. Hofbauer, Pascal Houillier, Aliya A. Khan, Michael A. Levine, Michael Mannstadt, Dolores M. Shoback, Tamara J. Vokes, Pinggao Zhang, Claudio Marelli, John Germak, Bart L. Clarke
Format: Article
Language:English
Published: BMC 2021-11-01
Series:BMC Endocrine Disorders
Subjects:
Chronic hypoparathyroidism
parathyroid hormone, patient registry
quality of life, rhPTH(1-84)
symptoms
Online Access:https://doi.org/10.1186/s12902-021-00888-2

Internet

https://doi.org/10.1186/s12902-021-00888-2

Similar Items